GlassScriptPhysician profile
Michael Diclemente
NPI 1639160088
$1,523.38
in general payments reported to CMS, 2019-2025
21 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.66 · 2020: $16.21 · 2021: $156 · 2022: $114 · 2023: $563 · 2024: $488 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $292.34 | 2023-2024 | Tisseel |
| Caldera Medical, INC | $234.51 | 2024 | Desara |
| Astellas Pharma US INC | $163.74 | 2019-2023 | Myrbetriq |
| Amgen INC. | $125.00 | 2023 | Evenity |
| Dysis Medical, INC. | $120.35 | 2021 | |
| Myovant Sciences INC. | $78.44 | 2022 | |
| Minerva Surgical, INC | $74.51 | 2024 | |
| Abbvie INC. | $69.21 | 2019-2023 | Liletta |
| Bayer Healthcare Pharmaceuticals INC. | $61.65 | 2023-2025 | |
| Evofem Biosciences, INC. | $53.88 | 2020-2023 | Phexxi |
| Biogen, INC. | $47.01 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $30.84 | 2023-2025 | Gemtesa, Myfembree |
| Medtronic, INC. | $26.18 | 2023 | Interstim |
| Coopersurgical, INC. | $22.51 | 2023 | Endosee |
| Meditrina | $21.28 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.16 | 2023 | Cologuard Collection Kit |
| Exeltis, USA INC. | $18.10 | 2023 | Slynd |
| Organon LLC | $17.47 | 2022 | |
| Hologic Sales and Service, LLC | $16.89 | 2025 | Aptima |
| Aspira Women'S Health INC | $14.28 | 2024 | Ova1 |
| Conmed Corporation | $14.03 | 2023 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Diclemente listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.